$935 MillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$79.5 MillionTotal revenue in the last quarter.
-$66.5 MillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
-$9.77Earnings per share is the amount of net income that is attributed to each single share outstanding.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-2.91xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$-41.8 MillionEarnings before interest expenses and taxes in the last quarter.
0The number of full time employees.
SHENZHEN, China & ROCKVILLE, Md.--(BUSINESS WIRE)--HighTide Therapeutics Inc. (“HighTide”), a clinical-stage biopharmaceutical company, today announced the appointment of Leigh MacConell, Ph.D., as...Business Wire, about 1 month ago
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and…GlobeNewswire, about 2 months ago
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. and certain of its officers, on behalf of shareholders… | Ja...MarketScreener, 2 months ago